Comparison of Promiscuous and Tissue-Targeted AAV Gene Therapy for Systemic Propionic Acidemia Treatment

被引：0
|
作者：
Guenzel, Adam J. [1 ]
Hillestad, Matthew L. [1 ]
Barry, Michael A. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
MOLECULAR THERAPY | 2014年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
360
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [41] Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia
    An, Ding
    Schneller, Jessica L.
    Frassetto, Andrea
    Liang, Shi
    Zhu, Xuling
    Park, Ji-Sun
    Theisen, Matt
    Hong, Sue-Jean
    Zhou, Jenny
    Rajendran, Raj
    Levy, Becca
    Howell, Rebecca
    Besin, Gilles
    Presnyak, Vladimir
    Sabnis, Staci
    Murphy-Benenato, Kerry E.
    Kumarasinghe, E. Sathyajith
    Salerno, Timothy
    Mihai, Cosmin
    Lukacs, Christine M.
    Chandler, Randy J.
    Guey, Lin T.
    Venditti, Charles P.
    Martini, Paolo G. V.
    CELL REPORTS, 2017, 21 (12): : 3548 - 3558
  • [42] Exploring the Natural History of Cobalamin B (cblB) type Methylmalonic Acidemia (MMA) to Guide the Development of Systemic AAV Gene Therapy
    Gebremariam, Abigael
    Mccoy, Samantha
    Pass, Alexandra R.
    Sloan, Jennifer L.
    Ferry, Susan
    Van Ryzin, Carol
    Choi, Eun-Young
    Shchelochkov, Oleg
    Manoli, Irini
    Venditti, Charles P.
    MOLECULAR THERAPY, 2022, 30 (04) : 478 - 478
  • [43] Treatment of Methylmalonic Acidemia by Targeted Integration of MUT into Albumin Using an Optimized Promoterless AAV Vector
    Venturoni, Leah E.
    Chandler, Randy J.
    Chau, Nelson
    Liao, Jing
    Kay, Mark A.
    Barzel, Adi
    Venditti, Charles P.
    MOLECULAR THERAPY, 2019, 27 (04) : 367 - 367
  • [44] Short-Term Rescue of Neonatal Lethality in a Mouse Model of Propionic Acidemia by Gene Therapy
    Hofherr, Sean E.
    Senac, Julien S.
    Chen, Christopher Y.
    Palmer, Donna J.
    Ng, Philip
    Barry, Michael A.
    HUMAN GENE THERAPY, 2009, 20 (02) : 169 - 180
  • [45] Improved AAV-Mediated Systemic Gene Therapy to Striated Muscles through Increased Tissue Perfusion
    Khadir, Fatemeh
    Chauhan, Monika
    Daugherty, Audrey L.
    Tinklenberg, Jennifer A.
    Kang, Peter B.
    Cade, W. Todd
    Pacak, Christina A.
    MOLECULAR THERAPY, 2023, 31 (04) : 107 - 107
  • [46] GENE THERAPY Capsida raises $140 million for targeted AAV gene therapies
    Cross, Ryan
    CHEMICAL & ENGINEERING NEWS, 2021, 99 (16) : 13 - 13
  • [47] Anc80 and SVP Rapamycin: A novel approach to AAV gene therapy for methylmalonic acidemia
    Chandler, R. J.
    Li, L.
    Andres-Mateos, E.
    Xiao, R.
    Ilyinski, P.
    Kishimoto, K. T.
    Vandenberghe, L.
    Venditti, C. P.
    HUMAN GENE THERAPY, 2017, 28 (12) : A70 - A70
  • [48] Publisher Correction: Systemic AAV vectors for widespread and targeted gene delivery in rodents
    Rosemary C. Challis
    Sripriya Ravindra Kumar
    Ken Y. Chan
    Collin Challis
    Keith Beadle
    Min J. Jang
    Hyun Min Kim
    Pradeep S. Rajendran
    John D. Tompkins
    Kalyanam Shivkumar
    Benjamin E. Deverman
    Viviana Gradinaru
    Nature Protocols, 2019, 14 : 2597 - 2597
  • [49] Targeted delivery of AAV-transduced mesenchymal stromal cells to hepatic tissue for ex vivo gene therapy
    Gabriel, Nishanth
    Samuel, Rekha
    Jayandharan, Giridhara R.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2017, 11 (05) : 1354 - 1364
  • [50] Gene Therapy for Methylmalonic and Propionic Acidemia Using the Novel Adeno-Associated Viral Vector 44.9
    Chandler, Randy J.
    DiPasquale, Giovanni
    Choi, Eun-Young
    Chiorini, Jay A.
    Venditti, Charles P.
    MOLECULAR THERAPY, 2021, 29 (04) : 237 - 237
12345